Header
Header
Article

New patent for Axsome drug AUVELITY – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Axsome drug AUVELITY


Annual Drug Patent Expirations for AUVELITY

Auvelity is a drug marketed by Axsome and is included in one NDA. It is available from one supplier. There are ninety-six patents protecting this drug.

This drug has one hundred and thirty-three patent family members in thirty countries.

The generic ingredient in AUVELITY is bupropion hydrochloride; dextromethorphan hydrobromide. One supplier is listed for this compound. Additional details are available on the bupropion hydrochloride; dextromethorphan hydrobromide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Axsome drug AUVELITY



Source link

Back to top button